Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Jäntti, Toni"" wg kryterium: Autor


Tytuł :
Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock.
Autorzy :
Hänninen, Mikko (AUTHOR)
Jäntti, Toni (AUTHOR) toni.
Tolppanen, Heli (AUTHOR)
Segersvärd, Heli (AUTHOR)
Tarvasmäki, Tuukka (AUTHOR)
Lassus, Johan (AUTHOR)
Vausort, Mélanie (AUTHOR)
Devaux, Yvan (AUTHOR)
Sionis, Alessandro (AUTHOR)
Tikkanen, Ilkka (AUTHOR)
Harjola, Veli-Pekka (AUTHOR)
Lakkisto, Päivi (AUTHOR)
Pokaż więcej
Źródło :
International Journal of Molecular Sciences. Nov2020, Vol. 21 Issue 21, p7925. 1p.
Czasopismo naukowe
Tytuł :
Circulating levels of microRNA 423-5p are associated with 90 day mortality in cardiogenic shock.
Autorzy :
Jäntti T; Department of Internal Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Segersvärd H; Minerva Foundation Institute for Medical Research and University of Helsinki, Helsinki, Finland.
Tolppanen H; Department of Cardiology, University of Helsinki and Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Tarvasmäki T; Department of Cardiology, University of Helsinki and Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Lassus J; Department of Cardiology, University of Helsinki and Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Devaux Y; Cardiovascular Research Unit, Luxembourg Institute of Health, Strassen, Luxembourg.
Vausort M; Cardiovascular Research Unit, Luxembourg Institute of Health, Strassen, Luxembourg.
Pulkki K; Department of Clinical Chemistry, University of Eastern Finland and Eastern Finland Laboratory Centre (ISLAB), Kuopio, Finland.
Sionis A; Intensive Cardiac Care Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute IIB-SantPau, Universidad Autónoma de Barcelona, Barcelona, Spain.
Bayes-Genis A; Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, and Department of Medicine, CIBERCV, Autonomous University of Barcelona, Barcelona, Spain.
Tikkanen I; Minerva Foundation Institute for Medical Research and University of Helsinki, Helsinki, Finland.; Division of Nephrology, University of Helsinki and Abdominal Center, Division of Nephrology, Helsinki University Hospital, Helsinki, Finland.
Lakkisto P; Minerva Foundation Institute for Medical Research and University of Helsinki, Helsinki, Finland.; Department of Clinical Chemistry, University of Helsinki and Department of Clinical Chemistry, Helsinki University Hospital, Helsinki, Finland.
Harjola VP; Division of Emergency Medicine, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland.
Pokaż więcej
Źródło :
ESC heart failure [ESC Heart Fail] 2019 Feb; Vol. 6 (1), pp. 98-102. Date of Electronic Publication: 2018 Nov 24.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
MicroRNAs/*blood
Risk Assessment/*methods
Shock, Cardiogenic/*blood
Aged ; Biomarkers/blood ; Cause of Death/trends ; Female ; Finland/epidemiology ; Follow-Up Studies ; Humans ; Male ; Prospective Studies ; Risk Factors ; Shock, Cardiogenic/mortality ; Survival Rate/trends ; Time Factors
Czasopismo naukowe
Tytuł :
Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock.
Autorzy :
Jäntti T; Internal Medicine, University of Helsinki and Department of Internal Medicine, Helsinki University Hospital, Helsinki, Finland. Electronic address: toni.jantti@fimnet.fi.
Tarvasmäki T; Emergency Medicine, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland.
Harjola VP; Emergency Medicine, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland.
Parissis J; Heart Failure Clinic, Secondary Cardiology Department, Attikon University Hospital, Athens, Greece.
Pulkki K; Department of Clinical Chemistry, University of Eastern Finland and Eastern Finland Laboratory Centre (ISLAB), Kuopio, Finland.
Sionis A; Intensive Cardiac Care Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute IIB-SantPau, Universidad Autónoma de Barcelona, Barcelona, Spain.
Silva-Cardoso J; Department of Cardiology, CINTESIS, Porto Medical School, São João Hospital Center, University of Porto, Porto, Portugal.
Køber L; Division of Heart Failure, Pulmonary Hypertension and Heart Transplantation, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Banaszewski M; Intensive Cardiac Therapy Clinic, Institute of Cardiology, Warsaw, Poland.
Spinar J; Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic.
Fuhrmann V; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tolonen J; Internal Medicine, University of Helsinki and Department of Internal Medicine, Helsinki University Hospital, Helsinki, Finland.
Carubelli V; Division of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University and Civil Hospital of Brescia, Brescia, Italy.
diSomma S; Department of Medical Sciences and Translational Medicine, Sant'Andrea Hospital, University of Rome Sapienza, Rome, Italy.
Mebazaa A; INSERM U942, University Paris Diderot, Paris, France; Department of Anesthesia and Critical Care, Hôpital Lariboisière, APHP, Paris, France.
Lassus J; Cardiology, University of Helsinki and Department of Cardiology, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Pokaż więcej
Corporate Authors :
CardShock investigators
Źródło :
The American journal of cardiology [Am J Cardiol] 2017 Oct 01; Vol. 120 (7), pp. 1090-1097. Date of Electronic Publication: 2017 Jul 14.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Alanine Transaminase/*blood
Alkaline Phosphatase/*blood
Liver Diseases/*diagnosis
Shock, Cardiogenic/*complications
Aged ; Europe/epidemiology ; Female ; Humans ; Incidence ; Liver Diseases/epidemiology ; Liver Diseases/etiology ; Liver Function Tests/statistics & numerical data ; Male ; Prevalence ; Prognosis ; Shock, Cardiogenic/blood ; Shock, Cardiogenic/mortality ; Survival Rate
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies